Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer

Clinics and Research in Hepatology and Gastroenterology

Volumn 40, Issue 3, 2016, Pages 357-365

  Park, Jae Young ^a   Sung, Ji Youn ^b   Lee, Juhie ^b   Park, Yong Koo ^b   Kim, Youn Wha ^b   Kim, Gou Young ^b   Won, Kyu Yeoun ^b   Lim, Sung Jig ^b  

^a Hallym University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CELL SURFACE RECEPTOR; CXCL12 PROTEIN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CAPILLARY DENSITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CANCER; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR VOLUME; MACROPHAGE; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; STOMACH TUMOR; VASCULARIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHEMOKINE CXCL12; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; STOMACH NEOPLASMS;

EID: 84951111766     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2015.09.005     Document Type: Article

References (37)

1. Allavena P., Sica A., Solinas G., Porta C., Mantovani A. The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008, 66(1):1-9.
2. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3(1):23-35.
3. Wu H., Xu J.B., He Y.L., Peng J.J., Zhang X.H., Chen C.Q., et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol 2012, 106(4):462-468.
4. Ishigami S., Natsugoe S., Tokuda K., Nakajo A., Okumura H., Matsumoto M., et al. Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res 2003, 23(5A):4079-4083.
5. Ch'ng E.S., Tuan Sharif S.E., Jaafar H. In human invasive breast ductal carcinoma, tumor stromal macrophages and tumor nest macrophages have distinct relationships with clinicopathological parameters and tumor angiogenesis. Virchows Arch 2013, 462(3):257-267.
6. Hanada T., Nakagawa M., Emoto A., Nomura T., Nasu N., Nomura Y. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 2000, 7(7):263-269.
7. Ohno S., Ohno Y., Suzuki N., Kamei T., Koike K., Inagawa H., et al. Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 2004, 24(5C):3335-3342.
8. Forssell J., Oberg A., Henriksson M.L., Stenling R., Jung A., Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 2007, 13(5):1472-1479.
9. Ohno S., Inagawa H., Dhar D.K., Fujii T., Ueda S., Tachibana M., et al. The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 2003, 23(6D):5015-5022.
10. Ambarus C.A., Krausz S., van Eijk M., Hamann J., Radstake T.R., Reedquist K.A., et al. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J Immunol Methods 2012, 375(1-2):196-206.
11. Ma J., Liu L., Che G., Yu N., Dai F., You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010, 10:112.
12. Medrek C., Ponten F., Jirstrom K., Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 2012, 12:306.
13. Lan C., Huang X., Lin S., Huang H., Cai Q., Wan T., et al. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat 2013, 12(3):259-267.
14. Kurahara H., Shinchi H., Mataki Y., Maemura K., Noma H., Kubo F., et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 2011, 167(2):e211-e219.
15. He K.F., Zhang L., Huang C.F., Ma S.R., Wang Y.F., Wang W.M., et al. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int 2014, 2014:838632.
16. Ohno S., Inagawa H., Soma G., Nagasue N. Role of tumor-associated macrophage in malignant tumors: should the location of the infiltrated macrophages be taken into account during evaluation?. Anticancer Res 2002, 22(6C):4269-4275.
17. Pantano F., Berti P., Guida F.M., Perrone G., Vincenzi B., Amato M.M., et al. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients. J Cell Mol Med 2013, 17(11):1415-1421.
18. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23(11):549-555.
19. Bingle L., Lewis C.E., Corke K.P., Reed M.W., Brown N.J. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 2006, 94(1):101-107.
20. Du J.R., Jiang Y., Zhang Y.M., Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. WJG 2003, 9(7):1604-1606.
21. Sharma S., Sharma M.C., Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005, 46(5):481-489.
22. Fonsatti E., Altomonte M., Nicotra M.R., Natali P.G., Maio M. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003, 22(42):6557-6563.
23. Bachelder R.E., Wendt M.A., Mercurio A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002, 62(24):7203-7206.
24. Salcedo R., Wasserman K., Young H.A., Grimm M.C., Howard O.M., Anver M.R., et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999, 154(4):1125-1135.
25. Boimel P.J., Smirnova T., Zhou Z.N., Wyckoff J., Park H., Coniglio S.J., et al. Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res 2012, 14(1):R23.
26. Schioppa T., Uranchimeg B., Saccani A., Biswas S.K., Doni A., Rapisarda A., et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003, 198(9):1391-1402.
27. Sanchez-Martin L., Estecha A., Samaniego R., Sanchez-Ramon S., Vega M.A., Sanchez-Mateos P. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 2011, 117(1):88-97.
28. Rigo A., Gottardi M., Zamo A., Mauri P., Bonifacio M., Krampera M., et al. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12. Mol Cancer 2010, 9:273.
29. Ishigami S., Natsugoe S., Okumura H., Matsumoto M., Nakajo A., Uenosono Y., et al. Clinical implication of CXCL12 expression in gastric cancer. Ann Surg Oncol 2007, 14(11):3154-3158.
30. Ying J., Xu Q., Zhang G., Liu B., Zhu L. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis. Med Oncol 2012, 29(3):1716-1722.
31. Edge S.B., Byrd D.R., Compton C.C., et al. AJCC Cancer Staging Manual 2010, New York, Springer.
32. Zlobec I., Steele R., Terracciano L., Jass J.R., Lugli A. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 2007, 60(10):1112-1116.
33. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006, 66(23):11238-11246.
34. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002, 8(Suppl. 4):S62-S67.
35. Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001, 93(4):266-276. [Epub 2001/02/22].
36. Hagemann T., Robinson S.C., Schulz M., Trumper L., Balkwill F.R., Binder C. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 2004, 25(8):1543-1549.
37. Goswami S., Sahai E., Wyckoff J.B., Cammer M., Cox D., Pixley F.J., et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005, 65(12):5278-5283.